资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#SpA#
99篇内容 | 2308人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=7033165e692, topicName=SpA, introduction=SpA, content=null, image=null, comments=99, allHits=2308, url=https://h5.medsci.cn/topic?id=16576, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=40044, tagList=[TagDto(tagId=40044, tagName=SpA)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1989471, encodeId=9e4c19894e1a5, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=ARD:托珠单抗治疗新发风湿性多肌痛(PMR-SPARE):一项2/3期随机对照试验, objectType=article, longId=731063, objectId=3052e310638a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3052e310638a, replyNumber=0, likeNumber=129, createdTime=2022-08-23, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3052e310638a, moduleTitle=ARD:托珠单抗治疗新发风湿性多肌痛(PMR-SPARE):一项2/3期随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3052e310638a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989470, encodeId=b55f19894e0ba, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol:Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, objectType=article, longId=729628, objectId=bf1ee296289d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1ee296289d, replyNumber=0, likeNumber=98, createdTime=2022-10-15, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1ee296289d, moduleTitle=J Clin Oncol:Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1ee296289d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989468, encodeId=353f1989468ad, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=新型取栓技术(SPACEMAN)的技术考虑和应用场景:一项前瞻性研究, objectType=article, longId=300238, objectId=50113002384a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50113002384a, replyNumber=0, likeNumber=93, createdTime=2023-02-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50113002384a, moduleTitle=新型取栓技术(SPACEMAN)的技术考虑和应用场景:一项前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50113002384a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989465, encodeId=4f3a19894655f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Diabetes:COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中, objectType=article, longId=219565, objectId=dbdc219565c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbdc219565c4, replyNumber=0, likeNumber=93, createdTime=2022-03-10, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbdc219565c4, moduleTitle=Diabetes:COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbdc219565c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989469, encodeId=b21619894691f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=ATVB:Caspase-8通过激活炎症因子的产生促进肺动脉高压, objectType=article, longId=723924, objectId=3d21e2392495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d21e2392495, replyNumber=0, likeNumber=86, createdTime=2022-07-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d21e2392495, moduleTitle=ATVB:Caspase-8通过激活炎症因子的产生促进肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d21e2392495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989466, encodeId=659519894661f, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol:III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib(达拉非尼)+ Trametinib(曲美替尼)治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效, objectType=article, longId=294057, objectId=20b829405e40, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20b829405e40, replyNumber=0, likeNumber=52, createdTime=2022-09-07, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20b829405e40, moduleTitle=J Clin Oncol:III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib(达拉非尼)+ Trametinib(曲美替尼)治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20b829405e40)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989463, encodeId=d19c198946393, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=数字疗法巨头诞生!心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元, objectType=article, longId=216323, objectId=2b552163233a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b552163233a, replyNumber=0, likeNumber=79, createdTime=2021-12-11, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b552163233a, moduleTitle=数字疗法巨头诞生!心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b552163233a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989467, encodeId=5235198946e4e, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Front Immunol:联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用, objectType=article, longId=294149, objectId=12f429414970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12f429414970, replyNumber=0, likeNumber=82, createdTime=2022-05-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12f429414970, moduleTitle=Front Immunol:联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12f429414970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989462, encodeId=64891989462a8, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=J Clin Oncol:Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性, objectType=article, longId=214106, objectId=eb67214106de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb67214106de, replyNumber=0, likeNumber=68, createdTime=2021-11-24, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb67214106de, moduleTitle=J Clin Oncol:Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb67214106de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989460, encodeId=2adb1989460d1, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Nat Commun:CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标, objectType=article, longId=208290, objectId=058f2082904e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=058f2082904e, replyNumber=0, likeNumber=83, createdTime=2021-05-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=058f2082904e, moduleTitle=Nat Commun:CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=058f2082904e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989464, encodeId=d47e19894649a, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH),已获得欧盟CHMP积极意见, objectType=article, longId=218729, objectId=4cd6218e291b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cd6218e291b, replyNumber=0, likeNumber=69, createdTime=2022-02-25, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cd6218e291b, moduleTitle=Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH),已获得欧盟CHMP积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cd6218e291b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989461, encodeId=1d67198946131, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=SpaceX星舰SN15超预期平稳着陆,曹原石墨烯研究再获新突破 | 一周科技导读, objectType=article, longId=211092, objectId=2edc2110923e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2edc2110923e, replyNumber=0, likeNumber=76, createdTime=2021-09-04, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2edc2110923e, moduleTitle=SpaceX星舰SN15超预期平稳着陆,曹原石墨烯研究再获新突破 | 一周科技导读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2edc2110923e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989458, encodeId=73f2198945896, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=SPATA:基因集驱动的空间转录组分析框架, objectType=article, longId=206865, objectId=c5f920686566, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5f920686566, replyNumber=0, likeNumber=80, createdTime=2021-02-20, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5f920686566, moduleTitle=SPATA:基因集驱动的空间转录组分析框架, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5f920686566)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989455, encodeId=69ae19894552b, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Differ:SPAP5的异常表达促进乳腺癌细胞的增殖, objectType=article, longId=203858, objectId=c7e6203858a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e6203858a0, replyNumber=0, likeNumber=75, createdTime=2021-04-13, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e6203858a0, moduleTitle=Cell Death Differ:SPAP5的异常表达促进乳腺癌细胞的增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e6203858a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989457, encodeId=446c198945e75, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=百时美施贵宝血液病创新药Luspatercept上市申请获CDE优先审评, objectType=article, longId=206759, objectId=7050206e59ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7050206e59ba, replyNumber=0, likeNumber=81, createdTime=2021-08-09, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7050206e59ba, moduleTitle=百时美施贵宝血液病创新药Luspatercept上市申请获CDE优先审评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7050206e59ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989453, encodeId=4a021989453f1, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=轻轻松松掌握文献知识图谱,发现科研创新思路——CiteSpace, objectType=article, longId=200626, objectId=b4b12006261d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b12006261d, replyNumber=0, likeNumber=83, createdTime=2021-01-20, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b12006261d, moduleTitle=轻轻松松掌握文献知识图谱,发现科研创新思路——CiteSpace, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b12006261d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989450, encodeId=27ee198945095, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Host & Microbe:情绪牵肠道!脸上带smile,肠道做SPA!, objectType=article, longId=195681, objectId=ecee19568113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecee19568113, replyNumber=0, likeNumber=105, createdTime=2020-09-21, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecee19568113, moduleTitle=Cell Host & Microbe:情绪牵肠道!脸上带smile,肠道做SPA!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecee19568113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989449, encodeId=207b19894497c, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Diff:HSPA12A可作为LPS诱导性肝损伤的治疗靶点, objectType=article, longId=193627, objectId=519819362ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519819362ec1, replyNumber=0, likeNumber=76, createdTime=2021-01-03, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519819362ec1, moduleTitle=Cell Death Diff:HSPA12A可作为LPS诱导性肝损伤的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=519819362ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989459, encodeId=1ba81989459dc, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Sparsentan治疗IgA肾病(IgAN),EMA已授予Sparsentan“孤儿药称号”, objectType=article, longId=207390, objectId=460c20e390d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460c20e390d3, replyNumber=0, likeNumber=98, createdTime=2022-01-29, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460c20e390d3, moduleTitle=Sparsentan治疗IgA肾病(IgAN),EMA已授予Sparsentan“孤儿药称号”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=460c20e390d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989454, encodeId=fa3e198945431, content=<a href='/topic/show?id=7033165e692' target=_blank style='color:#2F92EE;'>#SpA#</a>, objectTitle=Cell Death Dis:SPATS2调控细胞周期促进肝癌的发生发展, objectType=article, longId=202307, objectId=195120230ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195120230ef9, replyNumber=0, likeNumber=99, createdTime=2021-08-06, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195120230ef9, moduleTitle=Cell Death Dis:SPATS2调控细胞周期促进肝癌的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195120230ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
SpA
2020-05-29
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
ARD:托珠单抗治疗新发风湿性多肌痛(PMR-SPARE):一项2/3期随机对照试验
129
0
2022-08-23
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
J Clin Oncol:Spartalizumab 联合达拉非尼和曲美替尼治疗黑色素瘤的疗效
98
0
2022-10-15
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
新型取栓技术(SPACEMAN)的技术考虑和应用场景:一项前瞻性研究
93
0
2023-02-13
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
Diabetes:COVID-19的老年肥胖糖尿病患者可能通过GRP78 (BIP/HSPA5)参与到脂肪组织中
93
0
2022-03-10
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
ATVB:Caspase-8通过激活炎症因子的产生促进肺动脉高压
86
0
2022-07-13
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
J Clin Oncol:III期临床研究评估PD-1抑制剂Spartalizumab 联合Dabrafenib(达拉非尼)+ Trametinib(曲美替尼)治疗BRAF V600突变不可切除或转移性黑色素瘤的疗效
52
0
2022-09-07
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
数字疗法巨头诞生!心理健康巨头Headspace 和 Ginger 合并市值超30 亿美元
79
0
2021-12-11
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
Front Immunol:联合治疗通过抑制Caspase-1/Gasdermin D诱导狼疮性肾炎细胞焦亡的新作用
82
0
2022-05-27
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
J Clin Oncol:Pegaspargase和Calaspargase Pegol治疗儿童ALL的疗效和毒性
68
0
2021-11-24
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
Nat Commun:CD318、TSPAN8和CD66c为胰腺癌CAR-T细胞疗法的候选靶标
83
0
2021-05-27
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
Aspaveli (pegcetacoplan) 治疗阵发性夜间血红蛋白尿症 (PNH),已获得欧盟CHMP积极意见
69
0
2022-02-25
回复
gostraight
(审核中...)
关注
已关注
前往app查看评论内容
#SpA#
SpaceX星舰SN15超预期平稳着陆,曹原石墨烯研究再获新突破 | 一周科技导读
76
0
2021-09-04
回复
gostraight
(审核中...)
关注